16:01 Jan 01
Vanta Bioscience Ltd.
Sector Diversified Consumer Services
Industry Healthcare Services
Vanta Bioscience Ltd.
Industry Healthcare Services
16:01 Jan 01
Quality
0/100
Not Eligible
Valuation
25/100
Expensive Valuation
Technical
27/100
Technically Bearish
Strength
4
Weakness
6
Opportunity
0
Threats
0
-15.23 %
ROE %
-2.71 %
ROA %
0.00
EPS
24.08
BVPS
-23.81 %
Net Profit Margin
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
|---|---|---|---|---|---|---|
| Net Sales | 14.14 | 10.04 | 9.69 | 6.28 | 9.72 | |
| Operating Expenses + | 9.77 | 6.09 | 6.21 | 8.67 | 8.41 | |
| Raw Material | 1.18 | 0.82 | 0.7 | 0.83 | 1.1 | |
| Increase Decrease in Cost | 0 | 0 | 0 | 0.11 | -0.38 | |
| Other Manufacturing Expense | 0 | 0 | 0 | 0 | 0 | |
| Employee Cost | 5.07 | 2.83 | 3.09 | 3.94 | 3.79 | |
| Miscellaneous Expenses | 3.52 | 2.44 | 2.42 | 3.79 | 3.9 | |
| Operating Profit | 4.37 | 3.95 | 3.48 | -2.39 | 1.31 | |
| Other Income | 0.11 | 0.03 | 0.42 | 0.69 | 0.11 | |
| Depreciation | 1.19 | 1.25 | 1.32 | 2.67 | 4.5 | |
| Interest | 1.95 | 2.14 | 2.35 | 5.89 | 5.75 | |
| Profit before tax and exceptio.. | 1.34 | 0.59 | 0.23 | -10.26 | -8.83 | |
| Exceptional Items | 0 | 0 | 0 | 0 | 0 | |
| PBT | 1.34 | 0.59 | 0.23 | -10.26 | -8.83 | |
| Provision for Taxation | 0.33 | 0.14 | 0.09 | 0.18 | -0.22 | |
| Net Profit | 1.01 | 0.45 | 0.13 | -10.44 | -8.61 | |
| NET Profit after MI | 1 | 0.45 | 0.09 | -6.48 | -2.32 | |
| EPS | 1.56 | 0.07 | 0.14 | -10.27 | -3.67 | |
| Operating Profit Margin (%) | 30.91 | 39.34 | 35.91 | -38.06 | 13.48 | |
| Net Profit Margin (%) | 7.07 | 4.48 | 0.93 | -103.18 | -23.87 |
ShareHolding
Promoter
FII
Public
Mutual Funds
Other Institutions
All Data in Percentage (%)
| Sep 24 | Mar 24 | |
|---|---|---|
| Promoter | 69.40 | 69.40 |
| FII | 0.00 | 0.00 |
| MF | 0.00 | 0.00 |
| Public | 30.60 | 30.60 |
| Others | 0.00 | 0.00 |
| Others | 0.00 | 0.00 |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
